BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36387144)

  • 21. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.
    Coyaud E; Struski S; Prade N; Familiades J; Eichner R; Quelen C; Bousquet M; Mugneret F; Talmant P; Pages MP; Lefebvre C; Penther D; Lippert E; Nadal N; Taviaux S; Poppe B; Luquet I; Baranger L; Eclache V; Radford I; Barin C; Mozziconacci MJ; Lafage-Pochitaloff M; Antoine-Poirel H; Charrin C; Perot C; Terre C; Brousset P; Dastugue N; Broccardo C
    Blood; 2010 Apr; 115(15):3089-97. PubMed ID: 20160164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
    Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
    J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.
    Sigvardsson M
    Genes Dev; 2023 Aug; 37(15-16):703-723. PubMed ID: 37673459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation.
    Jurado S; Fedl AS; Jaritz M; Kostanova-Poliakova D; Malin SG; Mullighan CG; Strehl S; Fischer M; Busslinger M
    EMBO J; 2022 Apr; 41(7):e108397. PubMed ID: 35156727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.
    Li Z; Lee SHR; Chin WHN; Lu Y; Jiang N; Lim EH; Coustan-Smith E; Chiew KH; Oh BLZ; Koh GS; Chen Z; Kham SKY; Quah TC; Lin HP; Tan AM; Ariffin H; Yang JJ; Yeoh AE
    Blood Adv; 2021 Dec; 5(23):5226-5238. PubMed ID: 34547766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
    Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
    EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development.
    Fortschegger K; Anderl S; Denk D; Strehl S
    Mol Cancer Res; 2014 Apr; 12(4):595-606. PubMed ID: 24435167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.
    Hütter G; Kaiser M; Neumann M; Mossner M; Nowak D; Baldus CD; Gökbuget N; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2011 May; 35(5):614-9. PubMed ID: 21156323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans.
    Tachibana H; Daino K; Ishikawa A; Morioka T; Shang Y; Ogawa M; Matsuura A; Shimada Y; Kakinuma S
    Carcinogenesis; 2022 Aug; 43(7):693-703. PubMed ID: 35395675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic gatekeeper function of B-lymphoid transcription factors.
    Chan LN; Chen Z; Braas D; Lee JW; Xiao G; Geng H; Cosgun KN; Hurtz C; Shojaee S; Cazzaniga V; Schjerven H; Ernst T; Hochhaus A; Kornblau SM; Konopleva M; Pufall MA; Cazzaniga G; Liu GJ; Milne TA; Koeffler HP; Ross TS; Sánchez-García I; Borkhardt A; Yamamoto KR; Dickins RA; Graeber TG; Müschen M
    Nature; 2017 Feb; 542(7642):479-483. PubMed ID: 28192788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
    An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
    Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
    Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
    Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
    Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
    [No Abstract]   [Full Text] [Related]  

  • 38. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
    Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
    Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.